Hanna Lythgoe

Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS)

Susanna Felsenstein, Emily Willis, Hanna Lythgoe et al. · Journal of Clinical Medicine · 2020 · 74 citations · Full text

Clinical Symptoms, Immunodeficiencies, Covid-19 Epidemiology +20

Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytes

Kavitha Ramanathan, Anna Glaser, Hanna Lythgoe et al. · Lara D. Veeken · 2017 · 45 citations · Full text

Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis

Hanna Lythgoe, T A Morgan, Eleanor Heaf et al. · Lupus · 2017 · 33 citations

Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO

Athimalaipet V Ramanan, L Hampson, Hanna Lythgoe et al. · PLoS ONE · 2019 · 32 citations · Full text

Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management

Hanna Lythgoe, Beverley Almeida, Joshua Bennett et al. · Pediatric Rheumatology · 2018 · 26 citations · Full text